Home This week in gene and cell therapy - 7 September 2018 Gene and cell therapy headlines 3 - 7 September 4D Molecular Therapeutics partners with AstraZeneca and Roche to develop gene therapy products Clinical trial with iPS cell therapy for heart disease announced Vertex announces clinical trial of gene editing for beta thalassemia Immune response against gene therapy overcome with plasmid in mice Encouraging results for trial of Sangamo's trial of in vivo gene editing for Hunter syndrome T cell therapy achieves regression in metastatic liver cancer (7 month follow up)